Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity
Background: Co-existence of diabetes in the HIV infected reportedly further complicates the attendant impairment of immunity and increases susceptibility to opportunistic infections. Objective: This study aimed to evaluate some immune and inflammatory parameters in HIV and type 2 diabetes (T2D) co-m...
Saved in:
Published in | African health sciences Vol. 23; no. 1; pp. 120 - 8 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Uganda
Makerere Medical School
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: Co-existence of diabetes in the HIV infected reportedly further complicates the attendant impairment of immunity and increases susceptibility to opportunistic infections.
Objective: This study aimed to evaluate some immune and inflammatory parameters in HIV and type 2 diabetes (T2D) co-morbidity: Immunoglobulin M and G (IgM and IgG), Interleukin-6, CD4+ T-cells and C-reactive protein.
Method: The study involved 200 subjects grouped according to their HIV and diabetes status: Group 1 ‘Diabetic HIV seropositive’( n=40), Group 2 ‘Non diabetic HIV seropositive’(n=60), Group 3 ‘Diabetic HIV seronegative’(n=50), and Group 4 ‘Control non diabetic HIV seronegative’(n=50). Blood samples were collected for testing.
Results: CRP levels were significantly elevated in diabetes and HIV co-morbidity compared to other groups. IL–6 levels were significantly higher in diabetics with or without HIV infection. In addition, IL-6 was significantly elevated in individuals with poor glycemic control (HbA1c > 9.0%) compared to those with good glycemic control. IgG and IgM levels in diabetic HIV seropositive subjects were highest compared with other groups.
Conclusion: The increased IL-6, CRP, IgG, IgM and decreased CD4+ T cell counts observed in co-morbidity suggest that HIV and T2D co-morbidity exacerbate the immune and inflammatory impairment observed in either disease entity.
KeyWords: Diabetes; HIV; co-morbidity; immune responses; inflammation; glycemic control. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1680-6905 1729-0503 1729-0503 |
DOI: | 10.4314/ahs.v23i1.14 |